RU93003834A - A method for the treatment of rheumatoid arthritis and deforming osteoarthrosis - Google Patents

A method for the treatment of rheumatoid arthritis and deforming osteoarthrosis

Info

Publication number
RU93003834A
RU93003834A RU93003834/14A RU93003834A RU93003834A RU 93003834 A RU93003834 A RU 93003834A RU 93003834/14 A RU93003834/14 A RU 93003834/14A RU 93003834 A RU93003834 A RU 93003834A RU 93003834 A RU93003834 A RU 93003834A
Authority
RU
Russia
Prior art keywords
treatment
bischofite
lanolin
ointment
rheumatoid arthritis
Prior art date
Application number
RU93003834/14A
Other languages
Russian (ru)
Inventor
Г.В. Дзяк
А.Н. Зорин
Л.Д. Колесникова
В.В. Головкин
Л.И. Новоженина
Original Assignee
Г.В. Дзяк
А.Н. Зорин
Filing date
Publication date
Application filed by Г.В. Дзяк, А.Н. Зорин filed Critical Г.В. Дзяк
Publication of RU93003834A publication Critical patent/RU93003834A/en

Links

Claims (1)

Способ лечения ревматоидного артрита и деформирующего остеоартроза используется в медицине, в частности в ревматологии. Изобретение обеспечивает сокращение сроков лечения и продление периода ремиссии заболевания. Сущность изобретения: впервые бишофит используется в сочетании с другими веществами в виде мази, которую втирают в периартикулярные ткани 2 раза в день в течение 7-10 дней, в дальнейшем, при стихании воспалительных явлений, - 2 раза в день курсом 12-15 дней на фоне явления постперспирационной проницаемости кожного покрова. В состав мази входят компоненты: бишофит, димексид, анестезин, моноглицерид, сорбитан-олеат, ланолин в следующем количественном соотношении (мас. %): бишофит - 62,5-67,5; димексид - 7-9; анестезин - 2-3; моноглицерид - 10,5-12,5; сорбитанолеат - 1-1,5; ланолин - 11-16. Мазь, нанесенная предлагаемым способом, обладает хорошим обезболивающим и противовоспалительным действием, что сокращает сроки лечения и восстановления функции сустава; включение ланолиновой основы обеспечивает хорошую переносимость препарата.A method for the treatment of rheumatoid arthritis and osteoarthritis deformans is used in medicine, in particular in rheumatology. The invention provides a reduction in the duration of treatment and the extension of the remission period of the disease. The essence of the invention: for the first time, bischofite is used in combination with other substances in the form of an ointment, which is rubbed into periarticular tissues 2 times a day for 7-10 days, later, with inflammatory phenomena subsided, 2 times a day, for 12-15 days background of the phenomenon of postperspiration permeability of the skin. The composition of the ointment includes components: bischofite, dimexide, anestezin, monoglyceride, sorbitan-oleate, lanolin in the following proportion (wt.%): Bischofite - 62.5-67.5; Dimexide - 7-9; anestezin - 2-3; monoglyceride - 10.5-12.5; sorbitanoleate - 1-1.5; lanolin - 11-16. The ointment applied by the proposed method has a good analgesic and anti-inflammatory effect, which reduces the time of treatment and restoration of joint function; the inclusion of a lanolin base ensures good tolerability of the drug.
RU93003834/14A 1993-01-26 A method for the treatment of rheumatoid arthritis and deforming osteoarthrosis RU93003834A (en)

Publications (1)

Publication Number Publication Date
RU93003834A true RU93003834A (en) 1995-12-10

Family

ID=

Similar Documents

Publication Publication Date Title
CA2258920A1 (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
MX163955B (en) PHARMACEUTICAL COMPOSITION OF DIHYDROCODEINE AND IBUPROFEN
RU93043625A (en) COMPOSITION INCLUDING TRAMADOL AND ACETAMINOPHEN SUBSTANCE, AND METHOD OF TREATMENT WITH ITS USE
CA2148907A1 (en) Treatment of inflammatory bowel disease with ifn-gamma inhibitors
CA2126611A1 (en) Opiod Formulations Having Extended Controlled Release
DE122005000001I2 (en) Divalent metal salts of 2-N, N-di (carboxymethyl) amino-3-cyano-4-carboxymethyl-5-carboxy-thiophenic acid, processes for their preparation and pharmaceutical compositions containing them
WO1994012219A3 (en) Modified insulin-like growth factors
DE60228761D1 (en) PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND WITH IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) EFFECT AND ITS USE
RU93058379A (en) PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM, METHOD FOR PRODUCING THE COMPOSITION AND ITS APPLICATION
DE69724451D1 (en) COMBINATION THERAPY WITH A TNF-BINDING PROTEIN FOR TREATING DISEASES CAUSED BY TNF
RU93004907A (en) Hydroxamic Acid Derivatives and N-Hydroxyurea. METHOD FOR PRODUCING THE PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
NO307645B1 (en) Use of probenecid in combination with an excitatory amino acid antagonist for the preparation of a pharmaceutical composition
KR910019618A (en) Pharmaceutical composition for treating erectile dysfunction
CA2112907A1 (en) Peptide which abrogates tnf and/or lps toxicity
TW225536B (en)
DE69420827T2 (en) Process for the preparation of aqueous emulsions for the coating of solid pharmaceutical compositions
ATE226428T1 (en) METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS
EP0647616A4 (en) Zinc tranexamate compound.
DE69531736D1 (en) MEDICINAL PRODUCT CONTAINING OXYTETRACYCLIN WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE
RU93003834A (en) A method for the treatment of rheumatoid arthritis and deforming osteoarthrosis
IL131216A (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
KR900011461A (en) Therapeutics using trypstatin as an active ingredient
ATE14437T1 (en) AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SUCH DERIVATIVES FOR USE AS MEDICINAL PRODUCTS.
NO308195B1 (en) Use of benzydamine for the manufacture of a medicament in the treatment of pathological conditions caused by TNF
EP0477178B1 (en) Therapeutic composition and kit for the treatment of rhumatoid polyarthritis